Request Deal Involvement

Arcadia Investment Partners-backed Cristae Therapeutics completed the acquisition of a novel bile-acid therapeutics business from Advent International for $25m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

CMS Legal

legal advisors

CMS Legal

or

Principals

CRISTAE THERAPEUTICS

bidder

CRISTAE THERAPEUTICS

ADVENT INTERNATIONAL (NOVEL BILE-ACID THERAPEUTICS BUSINESS)

target

ADVENT INTERNATIONAL (NOVEL BILE-ACID THERAPEUTICS BUSINESS)

ADVENT INTERNATIONAL CORPORATION

vendor

ADVENT INTERNATIONAL CORPORATION

ARCADIA INVESTMENT PARTNERS

bidder

ARCADIA INVESTMENT PARTNERS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Arcadia Investment Partners-backed Cristae Therapeutics completed the acquisition of a novel bile-acid therapeutics business from Advent International for $25m.